The Latest Anti-Drug Industry Media Firestorm: Unscientific, Dishonest, and Dangerous
By Sandip Shah and Helen Shao
Have drug companies been lying about their development costs to justify high prices?
You'd be forgiven for thinking so, given the media's portrayal of a new study published in the prestigious journal JAMA Internal Medicine. The study reaches a shocking conclusion -- it costs just $648 million to develop a cancer drug. The prevailing estimate, from Tufts University, is $2.7 billion.